David Cordani - Apr 18, 2022 Form 4 Insider Report for Cigna Corp (CI)

Role
Chairman & CEO, Director
Signature
By: Jill M. Stadelman, attorney-in-fact
Stock symbol
CI
Transactions as of
Apr 18, 2022
Transactions value $
-$6,371,652
Form type
4
Date filed
4/20/2022, 06:06 PM
Previous filing
Mar 3, 2022
Next filing
Apr 22, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CI Common Stock, $.01 Par Value Options Exercise $449K +3.72K +2.56% $120.90 149K Apr 18, 2022 Direct F1
transaction CI Common Stock, $.01 Par Value Sale -$484K -1.85K -1.24% $261.18 147K Apr 18, 2022 Direct F1, F2
transaction CI Common Stock, $.01 Par Value Sale -$486K -1.86K -1.27% $260.61 145K Apr 18, 2022 Direct F1, F3
transaction CI Common Stock, $.01 Par Value Options Exercise $5.05M +41.8K +28.79% $120.90 187K Apr 19, 2022 Direct F1
transaction CI Common Stock, $.01 Par Value Sale -$119K -453 -0.24% $262.09 186K Apr 19, 2022 Direct F1, F4
transaction CI Common Stock, $.01 Par Value Sale -$4.49M -17.2K -9.21% $261.47 169K Apr 19, 2022 Direct F1, F5
transaction CI Common Stock, $.01 Par Value Sale -$6.29M -24.2K -14.27% $260.50 145K Apr 19, 2022 Direct F1, F6
holding CI Common Stock, $.01 Par Value 1.68K Apr 18, 2022 By 401(k) F7
holding CI Common Stock, $.01 Par Value 371K Apr 18, 2022 By GRAT
holding CI Common Stock, $.01 Par Value 39.8K Apr 18, 2022 By Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CI Employee Stock Option (Right to Buy) Options Exercise $0 -3.72K -2.33% $0.00 156K Apr 18, 2022 Common Stock, $.01 Par Value 3.72K $120.90 Direct F1, F8
transaction CI Employee Stock Option (Right to Buy) Options Exercise $0 -41.8K -26.84% $0.00 114K Apr 19, 2022 Common Stock, $.01 Par Value 41.8K $120.90 Direct F1, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2022.
F2 Represents the weighted average price of the shares sold. The prices actually received ranged from $261.005 to $261.42 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.
F3 Represents the weighted average price of the shares sold. The prices actually received ranged from $260.00 to $260.98 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.
F4 Represents the weighted average price of the shares sold. The prices actually received ranged from $262.04 to $262.15 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.
F5 Represents the weighted average price of the shares sold. The prices actually received ranged from $261.00 to $261.94 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.
F6 Represents the weighted average price of the shares sold. The prices actually received ranged from $260.00 to $260.99 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.
F7 Represents shares acquired through ongoing participation in Cigna's 401(k) Plan.
F8 This option was granted on February 25, 2015. The option vested in three equal annual installments on the first, second and third anniversaries of the grant date.